UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know

In the latest trading session, UnitedHealth Group (UNH) closed at $486.04, marking a +1.21% move from the previous day. This move outpaced the S&P 500's daily loss of 0.76%. Meanwhile, the Dow experienced a drop of 1.14%, and the technology-dominated Nasdaq saw a decrease of 0.18%.The the stock of largest U.S. health insurer has fallen by 9.96% in the past month, lagging the Medical sector's loss of 0.37% and the S&P 500's loss of 7.29%.Investors will be eagerly watching for the performance of UnitedHealth Group in its upcoming earnings disclosure. The company is forecasted to report an EPS of $7.24, showcasing a 4.78% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $111.01 billion, up 11.24% from the year-ago period.For the full year, the Zacks Consensus Estimates are projecting earnings of $29.54 per share and revenue of $451.2 billion, which would represent changes of +6.8% and +12.72%, respectively, from the prior year.Any recent changes to analyst estimates for UnitedHealth Group should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, UnitedHealth Group possesses a Zacks Rank of #3 (Hold).In terms of valuation, UnitedHealth Group is currently trading at a Forward P/E ratio of 16.26. This valuation marks a premium compared to its industry's average Forward P/E of 15.24.It's also important to note that UNH currently trades at a PEG ratio of 1.31. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. UNH's industry had an average PEG ratio of 1.15 as of yesterday's close.The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 182, positioning it in the bottom 28% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks